Review article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors.
about
Pharmacology of proton pump inhibitorsExpert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapyNrf2-inducing anti-oxidation stress response in the rat liver--new beneficial effect of lansoprazoleProton pump inhibitor formulary considerations in the acutely ill. Part 1: Pharmacology, pharmacodynamics, and available formulations.Proton pump inhibitor formulary considerations in the acutely ill. Part 2: Clinical efficacy, safety, and economics.Effect of clopidogrel on the hydroxylation and sulfoxidation of omeprazole: A single dose study in healthy human volunteers.Do the omeprazole family compounds exert a protective effect against influenza-like illness?Pantoprazole, a proton pump inhibitor, increases orthodontic tooth movement in ratsInfluences of different proton pump inhibitors on the anti-platelet function of clopidogrel in relation to CYP2C19 genotypesHelicobacter pylori infection--current treatment practice.Tenatoprazole, a novel proton pump inhibitor with a prolonged plasma half-life: effects on intragastric pH and comparison with esomeprazole in healthy volunteers.Lansoprazole: pharmacokinetics, pharmacodynamics and clinical uses.Pharmacogenetics of the proton pump inhibitors: a systematic review.A multicentre randomised trial to compare the efficacy of omeprazole versus rabeprazole in early symptom relief in patients with reflux esophagitis.Single vs. double dose of a proton pump inhibitor in triple therapy for Helicobacter pylori eradication: a meta-analysis.Repositioning proton pump inhibitors as anticancer drugs by targeting the thioesterase domain of human fatty acid synthaseClinical evidence of interaction between clopidogrel and proton pump inhibitorsSystematic review: Rabeprazole-based therapies in Helicobacter pylori eradication.Challenges of correlating pH change with relief of clinical symptoms in gastro esophageal reflux disease: a phase III, randomized study of Zegerid versus Losec.Meta-analysis: comparative efficacy of different proton-pump inhibitors in triple therapy for Helicobacter pylori eradication.The use of betaine HCl to enhance dasatinib absorption in healthy volunteers with rabeprazole-induced hypochlorhydria.Which PPI?Pharmacologic properties of proton pump inhibitors.Pharmacokinetics of two formulations of omeprazole administered through a gastrostomy tube in patients with severe neurodevelopmental problems.Application of nanoparticles for oral delivery of acid-labile lansoprazole in the treatment of gastric ulcer: in vitro and in vivo evaluations.Out-of-hospital use of proton pump inhibitors and hypomagnesemia at hospital admission: a nested case-control studyReview article: the pharmacodynamics and pharmacokinetics of proton pump inhibitors--overview and clinical implications.Review article: pH, healing and symptom relief with rabeprazole treatment in acid-related disorders.Proton pump inhibitors and vascular function: A prospective cross-over pilot studyThe Indications, Applications, and Risks of Proton Pump InhibitorsProton pump inhibitor monotherapy and the risk of cardiovascular events in patients with gastro-esophageal reflux disease: a meta-analysis.Proton Pump Inhibitors and the Risk of Osseointegrated Dental Implant Failure: A Cohort Study.In Vitro Evaluation of Nasogastric Tube Delivery Performance of Esomeprazole Magnesium Delayed-Release Capsules.Enhanced dissolution and stability of lansoprazole by cyclodextrin inclusion complexation: preparation, characterization, and molecular modelingReview article: the opportunities and benefits of extended acid suppression.Pharmacokinetics and pharmacodynamics of the proton pump inhibitors.A randomized, double blinded, clinical trial to assess the efficacy and cost effectiveness of omeprazole compared to rabeprazole in the maintenance therapy of patients with gastroesophageal reflux diseaseTreatment strategy to eradicate Helicobacter pylori infection: impact of pharmacogenomics-based acid inhibition regimen and alternative antibiotics.Population pharmacokinetics of omeprazole in a random Iranian population.Population pharmacokinetics of intravenous pantoprazole in paediatric intensive care patients
P2860
Q24634771-08DD08FE-3842-496F-926B-5B4C6CC83D52Q26998331-86C1A10A-9C03-40C0-A229-F714B56656D3Q28538990-CAB800A8-C1A5-4DB6-AB1E-0CD62C2228E3Q33222162-4F13C60E-3016-4FF1-BF25-5CBB485CF1C6Q33224563-E899AA51-6370-42DC-B9A0-3D8723E344C9Q33667262-7748461A-2622-4C03-93D3-E206FE7DF5A0Q33732181-D7F0FCBB-B44D-435D-9877-F3E00FBAD55BQ34065780-AE2BD245-1A7F-4E27-A255-F072594AFAACQ34174915-236A9DE3-9C01-4800-A039-4BBAF7854B77Q34240824-AD1175BB-F21A-48AA-A122-86E8EE458946Q34306075-3471085B-3E50-424D-88DA-6AF344ECC93BQ34515428-EE66181F-5B48-411A-9347-A2A842C78DADQ34532600-243578ED-4114-4FD9-8568-3283577EF9EAQ34647904-39584A7D-1D83-4026-9F2F-3E7EF0D67F45Q34657365-63FF2CC2-A195-421A-90FA-8017D7D27826Q35013508-7DC67EE5-32DF-4AF9-AF84-425B90E60853Q35033722-AC7DF5F2-2DE3-43FC-B6B5-78B485E2B7EAQ35086840-866ABB87-2B96-4EE1-A165-3D9228F9ECE0Q35112456-808510B1-3707-499C-8AC4-EB46076C8CEBQ35216889-3B345322-7507-439D-AF7C-8724EE251DACQ35318395-EF7D8F5A-7EF8-4112-8F53-C0F537B1E0A8Q35364687-F187FB62-7135-488F-A127-CEDE08090901Q35572512-9C590979-8925-4940-9A44-7DF7E606AD35Q35629813-54D926B0-AF5E-4E7E-8B97-C074CF50F932Q35766431-DBB77B69-F158-4D9B-8A5F-E0D0028C97B5Q35899886-2015B8CE-E4F3-44EF-94BA-0308A885317DQ35923949-74B80E23-3E8D-433A-AC75-A310163D4812Q35923964-21DAF206-18D2-4C88-A1B5-B2BC3877F072Q36067712-1259265D-409D-43B5-9195-7E20EEA393D0Q36091187-370093EA-19B7-4B26-A3D0-C8DE1DB20CD9Q36117874-0ADB201D-D7A2-4491-8088-5C1E01FFB0FFQ36170237-B1072B7A-BCA3-4E77-8344-BA7C1EB39D04Q36349085-051B9E4B-ED78-46C1-A109-43CA73DE0C43Q36442107-A3BE2703-D867-4B1C-9402-7A28ECE3E729Q36478875-27B0EB54-5E1E-49FC-99A8-47839ED68E9DQ36542670-2AFBDDC2-FC84-4421-A602-944793280834Q36817415-84AD4109-CCA8-4BD9-AFAE-D35168E64E79Q36979297-091F66CA-D4A2-4D33-850E-50EB4B99CF36Q37128495-FFCCFC11-5A6C-436E-9B74-2AC12F4B1A63Q37161518-94BFF50F-8816-40DB-A802-DEB4B95DEC0D
P2860
Review article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors.
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Review article: comparison of ...... acy of proton pump inhibitors.
@ast
Review article: comparison of ...... acy of proton pump inhibitors.
@en
type
label
Review article: comparison of ...... acy of proton pump inhibitors.
@ast
Review article: comparison of ...... acy of proton pump inhibitors.
@en
prefLabel
Review article: comparison of ...... acy of proton pump inhibitors.
@ast
Review article: comparison of ...... acy of proton pump inhibitors.
@en
P2860
P1476
Review article: comparison of ...... cacy of proton pump inhibitors
@en
P2093
C A Stedman
P2860
P304
P356
10.1046/J.1365-2036.2000.00788.X
P407
P577
2000-08-01T00:00:00Z